These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6230145)

  • 1. Inactivation of the scrapie agent by pronase.
    Cho HJ
    Can J Comp Med; 1983 Oct; 47(4):494-6. PubMed ID: 6230145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronase does not reduce the protein content of Hirt supernatant of normal mouse brain.
    Le Q Darcel C
    Ann Rech Vet; 1990; 21(1):75-9. PubMed ID: 1693052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of protein in scrapie agent infectivity.
    Lax AJ; Millson GC; Manning EJ
    Res Vet Sci; 1983 Mar; 34(2):155-8. PubMed ID: 6407080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow viruses: molecular properties of the agents causing scrapie in mice and hamsters.
    Prusiner SB; Cochran SP; Baringer JR; Groth D; Masiarz F; McKinley M; Bildstein C; Garfin D; Hadlow WJ; Race RE; Eklund CM
    Prog Clin Biol Res; 1980; 39():73-89. PubMed ID: 6773068
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoaffinity purification and neutralization of scrapie prions.
    Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
    Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different methods of purification on aggregation of scrapie infectivity.
    Castle BE; Dees C; German TL; Marsh RF
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():225-31. PubMed ID: 3100716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of scrapie infectivity to detergents and 2-mercaptoethanol.
    Somerville RA; Millson GC; Kimberlin RH
    Intervirology; 1980; 13(2):126-9. PubMed ID: 6768695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of scrapie agent from infected animal brains and raising of antibodies to the purified fraction.
    Takahashi K; Shinagawa M; Doi S; Sasaki S; Goto H; Sato G
    Microbiol Immunol; 1986; 30(2):123-31. PubMed ID: 3086675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure of RML scrapie agent to a sodium percarbonate-based product and sodium dodecyl sulfate renders PrPSc protease sensitive but does not eliminate infectivity.
    Smith JD; Nicholson EM; Foster GH; Greenlee JJ
    BMC Vet Res; 2013 Jan; 9():8. PubMed ID: 23311930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation of infectivity in purified fibrillary extracts of scrapie-infected hamster brain after sequential enzymatic digestion or polyacrylamide gel electrophoresis.
    Brown P; Liberski PP; Wolff A; Gajdusek DC
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7240-4. PubMed ID: 2119503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental scrapie in the mouse: electrophoretic and sedimentation properties of the partially purified agent.
    Prusiner SB; Garfin DE; Cochran SP; McKinley MP; Groth DF; Hadlow WJ; Race RE; Eklund CM
    J Neurochem; 1980 Sep; 35(3):574-82. PubMed ID: 6778963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration and distribution of infectivity and PrPSc following partial denaturation of a mouse-adapted and a hamster-adapted scrapie strain.
    Rubenstein R; Carp RI; Ju W; Scalici C; Papini M; Rubenstein A; Kascsak R
    Arch Virol; 1994; 139(3-4):301-11. PubMed ID: 7832637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent.
    Prusiner SB; Groth DF; Cochran SP; Masiarz FR; McKinley MP; Martinez HM
    Biochemistry; 1980 Oct; 19(21):4883-91. PubMed ID: 6775697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results and discussion. I. Polyacrylamide gel electrophoresis of SDS extracts of mouse brain subcellular fractions.
    Ann Inst Pasteur (Paris); 1972 Oct; 123(4):571-83. PubMed ID: 4632952
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a combinatorial approach to prion inactivation using an oxidizing agent, SDS, and proteinase K.
    Smith JD; Nicholson EM; Greenlee JJ
    BMC Vet Res; 2013 Jul; 9():151. PubMed ID: 23886483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophoretic properties of the scrapie agent in agarose gels.
    Prusiner SB; Groth DF; Bildstein C; Masiarz FR; McKinley MP; Cochran SP
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2984-8. PubMed ID: 6771764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of a protein component for scrapie infectivity.
    Cho HJ
    Intervirology; 1980; 14(3-4):213-6. PubMed ID: 6786997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents.
    Kimberlin RH; Walker CA; Millson GC; Taylor DM; Robertson PA; Tomlinson AH; Dickinson AG
    J Neurol Sci; 1983 Jun; 59(3):355-69. PubMed ID: 6308174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the scrapie agent in a scaled-down procedure for the purification of gangliosides from brain tissue.
    Di Martino A; Safar J; Ceroni M; Gibbs CJ
    Dev Biol Stand; 1993; 80():187-94. PubMed ID: 8270108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of non-infectious ganglioside preparations from scrapie-infected brain tissue.
    Di Martino A; Safar J; Ceroni M; Gibbs CJ
    Arch Virol; 1992; 124(1-2):111-21. PubMed ID: 1571012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.